These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6508511)

  • 1. [The anticoagulant arylalkyl- arylalkyidene-cyclopent-4-ene-1,3-diones].
    Rehse K; Lehmke J
    Arch Pharm (Weinheim); 1984 Sep; 317(9):781-9. PubMed ID: 6508511
    [No Abstract]   [Full Text] [Related]  

  • 2. [The anticoagulant 2,5-diarylcyclopent-4-ene-1,3-dione].
    Rehse K; Lehmke J
    Arch Pharm (Weinheim); 1984 Aug; 317(8):714-7. PubMed ID: 6497600
    [No Abstract]   [Full Text] [Related]  

  • 3. [Anticoagulant isoxazolidine-3,5-diones].
    Rehse K; Meder J
    Arch Pharm (Weinheim); 1986 Feb; 319(2):133-40. PubMed ID: 3707296
    [No Abstract]   [Full Text] [Related]  

  • 4. Molecular requirements of the active site of cholinergic receptors XV: Synthesis and biological activity of 2,3-dehydrodeoxamuscarone and 2,3-dehydrodeoxamuscarines.
    Angeli P; Brasili L; Giardinà D; Melchiorre C
    J Pharm Sci; 1981 May; 70(5):489-92. PubMed ID: 7241348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, cytotoxicity and antitumor activity of 2,3-diarylcyclopent-2-ene-1-ones.
    Nam NH; Kim Y; You YJ; Hong DH; Kim HM; Ahn BZ
    Arch Pharm Res; 2002 Oct; 25(5):600-7. PubMed ID: 12433189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antiaggregatory and anticoagulant effects of oligoamines. 12. Alkyl- and arylalkyl- derivatives of putrescine, spermidine and spermine].
    Rehse K; Puchert E; Leissring S
    Arch Pharm (Weinheim); 1990 May; 323(5):287-94. PubMed ID: 2383171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of new antineoplastic alkylidenecyclopentenones.
    Sugiura S; Hazato A; Tanaka T; Okamura N; Bannai K; Manabe K; Kurozumi S; Suzuki M; Noyori R
    Chem Pharm Bull (Tokyo); 1985 Sep; 33(9):4120-3. PubMed ID: 4092307
    [No Abstract]   [Full Text] [Related]  

  • 8. [Anticoagulant 3-aralkyl-4-hydroxy-2-pyrones].
    Rehse K; Schinkel W
    Arch Pharm (Weinheim); 1983 Dec; 316(12):988-94. PubMed ID: 6661006
    [No Abstract]   [Full Text] [Related]  

  • 9. [Anticoagulant 3-aryl-5-(phenylmethylene)tetronic acids].
    Rehse K; Lehmke J
    Arch Pharm (Weinheim); 1985 Jan; 318(1):11-4. PubMed ID: 3985769
    [No Abstract]   [Full Text] [Related]  

  • 10. [Anticoagulant activity of 3-arylalkyl-5-phenyltetronic acids].
    Rehse K; Emisch U
    Arch Pharm (Weinheim); 1982 Dec; 315(12):1020-5. PubMed ID: 7159189
    [No Abstract]   [Full Text] [Related]  

  • 11. Synthesis of novel potent hepatitis C virus NS3 protease inhibitors: discovery of 4-hydroxy-cyclopent-2-ene-1,2-dicarboxylic acid as a N-acyl-L-hydroxyproline bioisostere.
    Thorstensson F; Wångsell F; Kvarnström I; Vrang L; Hamelink E; Jansson K; Hallberg A; Rosenquist S; Samuelsson B
    Bioorg Med Chem; 2007 Jan; 15(2):827-38. PubMed ID: 17107807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tick repellents II: N-substituted azacyclopentanones and azacyclopentenones.
    Skinner WA; Rosentreter U; Elward T
    J Pharm Sci; 1983 Nov; 72(11):1354-6. PubMed ID: 6644605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anti-aggregatory and anticoagulant effects of oligoamines. 9. The pharmacokinetics of N,N',N"-tris-4-(3-iodo-4-methoxyphenyl)-butyl-1,3,5-benzene triethanamine].
    Rehse K; Buck W; Wenzel M
    Arch Pharm (Weinheim); 1988 Nov; 321(11):813-6. PubMed ID: 3219050
    [No Abstract]   [Full Text] [Related]  

  • 14. Cholinergic compounds. III - Synthesis and biological activity of epi-desmethyldesethermuscarine, desmethyldesethermuscarine and desmethyldesethermuscarone.
    Melchiorre C; Gualtieri F; Giannella M; Pigini M; Cingolani ML; Gamba G; Pigini P; Rossini L
    Farmaco Sci; 1975 Apr; 30(4):287-99. PubMed ID: 1183606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antiaggregatory and anticoagulant effects of oligoamines. 7. Benzene-1,3,5-trialkaneamines].
    Rehse K; Lükens U; Claus G
    Arch Pharm (Weinheim); 1987 Dec; 320(12):1233-8. PubMed ID: 3439865
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antiaggregative and anticoagulant effects of oligoamines. 8. Oligoamines with N-heterocyclic space structures].
    Rehse K; Mletzko S
    Arch Pharm (Weinheim); 1988 Sep; 321(9):533-6. PubMed ID: 3240067
    [No Abstract]   [Full Text] [Related]  

  • 17. Water soluble prodrugs of the antitumor agent 3-[(3-amino-4-methoxy)phenyl]-2-(3,4,5-trimethoxyphenyl)cyclopent-2-ene-1-one.
    Nam NH; Kim Y; You YJ; Hong DH; Kim HM; Ahn BZ
    Bioorg Med Chem; 2003 Mar; 11(6):1021-9. PubMed ID: 12614888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anti-aggregant and anticoagulant effects of oligoamines. II. P-phenylenebis(alkanamines)].
    Rehse K; Lükens U
    Arch Pharm (Weinheim); 1986 Jul; 319(7):603-7. PubMed ID: 3767617
    [No Abstract]   [Full Text] [Related]  

  • 19. [Anti-aggregation and anticoagulant effects of oligoamines. 3. M-phenylenebisaminoalkanes].
    Rehse K; Lükens U; Leissring S; Claus G
    Arch Pharm (Weinheim); 1987 Mar; 320(3):228-33. PubMed ID: 3579524
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antiaggregatory and anticoagulant effects of oligoamines. 5. Alicyclic di- and triamines].
    Rehse K; Carstensen A; Ernst HJ
    Arch Pharm (Weinheim); 1987 Sep; 320(9):829-36. PubMed ID: 3675171
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.